Two-Week DAA Prophylaxis Prevents Hep C After Kidney Transplant
TUESDAY, Nov. 28, 2023 -- Two-week direct-acting antiviral (DAA) prophylaxis prevents hepatitis C virus (HCV) infection in individuals without HCV viremia who received kidney transplant (KT) from donors with HCV viremia (HCV D+/R−), according...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Hepatitis | Hepatitis C | Kidney Transplant | Kidney Transplantation | Pharmaceuticals | Transplant Surgery | Transplants | Urology & Nephrology